Skip to content

Clinical Application and Mechanism Research of Circulating MicroRNA in Coronary Heart Disease

Clinical Application and Mechanism Research of Circulating MicroRNA in Coronary Heart Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16008235
Enrollment
Unknown
Registered
2016-04-07
Start date
2016-04-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Interventions

Gold Standard:
Index test:

Sponsors

Tangshan Gongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. The patients were diagnosed with unstable angina, STEMI or NSTEMI; 2. Agree on the coronary angiography examination.

Exclusion criteria

Exclusion criteria: Bleeding diathesis,recent stroke, uncontrolled hypertension, recent surgery, oral anticoagulant therapy, a limited life expectancy,severe hepatic and renal dysfunction, malignant tumour, malignant anemia, and known contraindications to therapy with aspirin, P2Y12 inhibitors, heparin or statin.

Design outcomes

Primary

MeasureTime frame
Plasma MicroRNAs;Gensini score;serum lipid;Hypersensitive c-reactive protein;Troponin I;CKMB;

Secondary

MeasureTime frame
hypertension history;History of diabetes;Smoking history;Body mass index;

Countries

China

Contacts

Public ContactLi Xia

Cardiovascular Department I, Tangshan Gongren Hospital

lixiats@126.com+86 13663373066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026